glp-1 for iih Receptor Agonists in Idiopathic Intracranial Hypertension: A Systematic Review | Headache Journal (Headache: The Journal of Head & Face Pain) posted on the topic Treatment with GLP-1 receptor agonists

Picking Your Most Optimal Injection Site GLP-1 medications are administered through subcutaneous injection

Its been consistent, real results. Average weight loss in 1 year is 11-20% (vs ~2-3% with diet and exercise alone)

Supports Cardiometabolic Health: GLP-1 therapies have demonstrated benefits for cardiovascular risk factors in multiple large clinical trials

At 40 weeks, participants saw average A1C reductions of: 1.3% with the low dose 1.6% with the middle dose 1.5% with the high dose This compares to a 0.1% reduction in the placebo group

Why A True GLP-1 Patch Is Unlikely To Work Right Now Are GLP-1 Patches Safe

J., Reimann, F